iHealth Labs

iHealth Labs manufactures FDA-authorized consumer health monitoring devices and at-home diagnostic tests. Since 2010, the company has developed wireless-enabled products including blood pressure monitors, glucose meters, thermometers, pulse oximeters, and rapid antigen tests. During the COVID-19 pandemic, iHealth became a major supplier of at-home tests to the U.S. federal government, distributing millions of test kits to states and counties nationwide.

The company's product ecosystem connects to a mobile application for data tracking and management. Through iHealth Unified Care, the company offers Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) programs designed to help healthcare providers manage patients with chronic conditions while generating reimbursement revenue. The platform advertises potential annual revenue additions of up to $200,000 per provider through these Medicare-reimbursable programs.

iHealth's devices are available for direct consumer purchase and through healthcare provider programs. Products feature FDA authorization, FSA/HSA eligibility, and clinical accuracy certifications for blood pressure and glucose monitoring systems.

Choose iHealth Labs when you need an established device manufacturer with proven government contracting experience and a ready-to-deploy RPM/CCM program. The company excels in providing consumer-accessible monitoring technology that meets clinical accuracy requirements while remaining FSA/HSA eligible and affordably priced for patient purchase programs.

Expect a technology-first approach with wireless connectivity as standard across product lines. The Unified Care program offers a structured path to RPM/CCM reimbursement for practices without existing infrastructure, though larger health systems may require more customization than the standardized offering provides.

iHealth Labs operates exclusively in the healthcare sector, manufacturing FDA-authorized medical devices for vital sign monitoring and diagnostic testing. The company serves both direct-to-consumer and healthcare provider markets with HIPAA-compliant remote monitoring solutions. Their Unified Care platform specifically addresses Medicare-reimbursable RPM and CCM programs, targeting primary care practices managing patients with hypertension, diabetes, and other chronic conditions requiring regular vital sign monitoring.

The company's government contracting experience demonstrates capacity for large-scale healthcare distribution programs, having supplied COVID-19 tests to federal, state, and county health departments across multiple states.

Small to mid-sized medical practices seeking to implement Remote Patient Monitoring or Chronic Care Management programs with minimal infrastructure investment. Primary care providers managing chronic disease populations who need affordable, patient-friendly monitoring devices. Healthcare organizations looking for consumer-accessible medical devices that patients can purchase independently while remaining clinically accurate.